passages.id: split_8_test_1902_passage
passages.type: progene_text
passages.text: Treatment of human melanoma cells with recombinant fibroblast interferon ( IFN-beta ) and the protein kinase C activator mezerein ( MEZ ) results in an irreversible loss in growth potential , suppression of tumorigenic properties and induction of terminal cell differentiation .